Sang Yeob Lee

Prof. Dr. Sang Yeob Lee


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
YKYeon A. Kim
Yeon A. Kim
JPJoon Beom Park
Joon Beom Park
MWMin Seok Woo
Min Seok Woo
SLSang Yeob Lee
Sang Yeob Lee
HKHye Young Kim
Hye Young Kim
YYYoung Hyun Yoo
Young Hyun Yoo
Persistent organic pollutants (POPs) such as organochlorine (OC) pesticides, polychlorinated biphenyls (PCBs), polychlorinated dibenzo-p-dioxins (PCDDs), and polychlorinated dibenzofurans (PCDFs) have become wide-spread environmental contaminants as a consequence of their extensive use, long-range transport, and persistence. Because POPs are highly resistant to metabolic degradation, humans bioaccumulate these lipophilic and hydrophobic pollutants in fatty tissues for many years. Previous studies have demonstrated that POPs including PCBs are involved in the development of diabetes mellitus (DM) type 2 and insulin resistance. Numerous epidemiological studies suggest an association between POP burden and DM type 2/metabolic syndrome. In addition, several experimental studies have provided additional evidence supporting the association between POP exposure and DM type 2 or insulin resistance. Epidemiological and experimental studies have provided compelling evidence indicating that exposure to POPs increases the risk of developing insulin resistance and metabolic disorders. However, the detailed molecular mechanism underlying POP-induced insulin resistance is yet to be elucidated. In this article, we review literature that has reported on the association between POP burden and insulin resistance and the mechanism underlying POP-induced insulin resistance, and discuss implications for public health.

1 December 2015 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
SLS.W. Lee
S.W. Lee
JRJ.H. Rho
J.H. Rho
SLSang Yeob Lee
Sang Yeob Lee
JKJ.H. Kim
J.H. Kim
JCJaeHun Cheong
JaeHun Cheong
YYYoung Hyun Yoo
Young Hyun Yoo

12 August 2022 in Medicine
Verified
Journal Article
Open access
JPJunyong Park
Junyong Park
SLSang Yeob Lee
Sang Yeob Lee
Numerous small-molecule inhibitors (SMIs) have been approved as adjuvant or first-line therapies for malignancies. Based on cancer treatment using SMIs, next-generation SMIs that can be used to optimize the therapeutic index, overcome drug resistance, and establish combination therapies are in development. Osteoarthritis (OA) is the most common chronic joint disease with senescence, and there are various approaches to OA treatment; however, the gold standard treatment is controversial. Therefore, in this manuscript, we demonstrated the potential of using SMIs in OA treatment and described the general strategies for using SMIs in OA treatment.

1 November 2018 in Medicine
Verified
Journal Article
Open access
SLSang Yeob Lee
Sang Yeob Lee
SLSung Won Lee
Sung Won Lee
WCWon Tae Chung
Won Tae Chung
Rationale: Dystrophic calcinosis occurs in chronically damaged tissue in patients with complicated autoimmune diseases. The therapeutic options are limited, and the treatment response rate is variable. Here, we describe a rare case of dystrophic calcinosis treated with leflunomide in a patient with overlap syndrome. Patient concerns: A 53-year-old woman who was diagnosed with overlaps syndrome (systemic sclerosis [SSc] with rheumatoid arthritis [RA]), presented to our hospital with pain and swelling in both wrists, and underwent radiography, bone scan, and biopsy examination. Diagnoses: This patient was diagnosed with dystrophic calcinosis in overlaps syndrome. Interventions: The conventional disease-modifying drugs were not effective. Hence, leflunomide was administered. Outcomes: Simple radiography and bone scan showed resolved mass-like dystrophic calcinosis on both wrists of the patient after the use of leflunomide. Lessons: The control of underlying disease is important in the treatment of dystrophic calcinosis. The use of leflunomide maybe an option in treatment of dystrophic calcinosis combined with RA.

1 January 2013 in The Korean Journal of Medicine
Verified
Journal Article
Open access
YKYong Jun Kim
Yong Jun Kim
SLSang Yeob Lee
Sang Yeob Lee

21 January 2022 in medRxiv
Verified
Preprint
Open access
PDF file
JPJunyong Park
Junyong Park
MSMinkook Son
Minkook Son
SLSung Won Lee
Sung Won Lee
WCWon Tae Chung
Won Tae Chung
SLSang Yeob Lee
Sang Yeob Lee
Hyperuricemia plays an essential role in the development of gout. Despite the clinical importance of hyperuricemia, a direct relationship between oral health and hyperuricemia has not been established. Therefore, we aim to investigate the association between oral health and hyperuricemia in Korean adults. We selected 17,584 subjects from the Korea National Health and Nutrition Examination Survey 2016–2019 database. Oral health-related variables included the number of dental caries, regular tooth brushing, use of secondary oral products, and regular dental examination. The odds ratio (OR) and 95% confidence intervals (CIs) for hyperuricemia were calculated using a multivariable-adjusted logistic regression model. In all subjects, oral health status with dental caries and oral health behaviors, including tooth brushing; secondary oral products; and regular dental examination, were significantly associated with hyperuricemia. The adjusted OR and 95% CIs for hyperuricemia comparing more than three dental caries with no dental caries were 1.28 (1.08–1.51). The adjusted OR and 95% CIs for hyperuricemia in regular tooth brushing, use of secondary oral products, and regular dental examination were 0.78 (0.67–0.91), 0.91 (0.82–1.00), and 0.86 (0.78–0.95), respectively. Notably, the association between oral health and hyperuricemia was more prominent in male subjects. In addition, when subjects were grouped by the scoring system regarding oral health, the prevalence of hyperuricemia was lower in groups with a better oral health score. In conclusion, we demonstrated that oral health status and behaviors were associated with hyperuricemia, especially in males. Further complementary studies are needed to confirm the definite association between oral health and hyperuricemia.